Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | AGER | Q15109 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24207966 | 1.00 | CA1 (0.57) | CA1CA2CA7CA9TSHR | |
| SCHEMBL30590458 | 1.00 | CA1 (0.57) | CA1CA2CA7CA9TSHR | |
| SCHEMBL3541327 | 0.91 | CA1 (0.62) | CA1CA2CA7CA9TSHR | |
| SCHEMBL16269805 | 0.89 | CA1 (0.70) | CA1CA2CA7CA9TSHR | |
| SCHEMBL508126 | 0.89 | CA1 (0.70) | CA1CA2CA7CA9TSHR | |
| SCHEMBL218661 | 0.89 | CA1 (0.70) | CA1CA2CA7CA9TSHR | |
| SCHEMBL122306 | 0.89 | CA1 (0.70) | CA1CA2CA7CA9TSHR | |
| SCHEMBL3545404 | 0.89 | CA1 (0.65) | CA1CA2CA7CA9TSHR | |
| SCHEMBL8270216 | 0.88 | CA1 (0.56) | CA1CA2CA7CA9TSHR | |
| SCHEMBL25435936 | 0.86 | CA1 (0.49) | CA1CA2CA7CA9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114305-A1 | LIPIDIC COMPOUNDS, AND USES THEREOF | SANOFI (FR) | 2025-04-10 | — | — | US | disclosed |
| EP-4466248-A1 | LIPIDIC COMPOUNDS, AND USES THEREOF | Sanofi (FR) | 2024-11-27 | — | — | EP | disclosed |
| CN-118829624-A | Lipid compound and use thereof | 赛诺菲 | 2024-10-22 | — | — | CN | disclosed |
| WO-2023135305-A1 | LIPIDIC COMPOUNDS, AND USES THEREOF | SANOFI (FR) | 2023-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114305-A1 | LIPIDIC COMPOUNDS, AND USES THEREOF | NR1H2, NR1H3, LPAR3 | CA1 2990/4885CA2 2496/4885CA7 2168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.